Neglected-disease research funding hits record high
Advocacy and research efforts are paying off as new treatments get approved.
Research funding for diseases that predominantly affect people living in poverty hit a record high in 2017, according to a report released on 23 January by Policy Cures Research, a global-health think tank in Sydney, Australia.
Anna Doubell, director of research at Policy Cures Research, says that the launch of several trials testing new Ebola drugs, diagnostics and vaccines in response to the Ebola crisis in West Africa between 2014 and 2016 might be giving donors hope that investments into neglected diseases pay off. “The amount of progress made in a short period of time after the Ebola outbreak might have brought in optimism about what is possible,” Doubell says.
By: Amy Maxmen/Nature News